Beone Medicines Ltd. Class A · SSE:688235
Baker Bros. Advisors LP sold 5,499 Beone Medicines Ltd. Class A shares (Form 4)
Traded May 22, 2026 · Filed May 27, 2026
On May 22, 2026, Baker Bros. Advisors LP (Director) sold 5,499 Beone Medicines Ltd. Class A shares at an average US$23.82 for US$131K, leaving 142,570 shares. Filed May 27, 2026 (Form 4).
- Sold
- 5,499 shares
- Price
- US$23.82 average (US$23.79 to US$23.85)
- Value
- US$131K
- Holding after
- 142,570 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 22, 2026 | Ordinary Shares | Sale | 2,743 | US$23.85 | 145,326 | Indirect |
| May 22, 2026 | Ordinary Shares | Sale | 2,756 | US$23.79 | 142,570 | Indirect |
Source
Related
- Beone Medicines Ltd. Class A
- Baker Bros. Advisors LP
- Beone Medicines Ltd. Class A shareholders
- Form 4 · Baker Bros. Advisors LP · Sep 16, 2026
- Form 4 · Wang Xiaodong · Oct 15, 2026
- Form 4 · Lee Chan Henry · Oct 2, 2026
- Form 4 · Wang Xiaodong · Sep 30, 2026
- Schedule 13D/A · Baker Bros. Advisors LP · Sep 16, 2026
- Form 4 · Wang Xiaodong · Sep 10, 2026